1 trial result announced this day (US Eastern).
| Time (ET) | Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|---|
| 8:07 AM | Firmonertinib Metastatic Non-Small Cell Lung Cancer | ArriVent (AVBP) | Missed | $28.46 | $14.59 | −48.74% |
Updated from the previous day
| Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|
| VAX-31 Pneumococcal Disease | Vaxcyte (PCVX) | Met | $56.48 | $72.99 | +29.23% |
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.